Exploring the Role of Oral JAK Inhibitors in Atopic Dermatitis - Episode 6
Laboratory Monitoring Plans for Oral JAK Inhibitors
Experts discuss the necessary monitoring for patients prescribed JAK inhibitors, emphasizing regular assessments for safety and effectiveness, with adjustments in the monitoring plan based on factors such as smoking status and age.
Video content above is prompted by the following:
What monitoring should be done once a patient is prescribed a JAK inhibitor? How often should a patient be monitored for safety and effectiveness?
a. Does smoking or age affect your monitoring plan?
